Daniel Tasse

Insider Reports History

Location
Clinton, NJ
Signature
/s/ Virginie Boucinha, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Tasse:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENXBIO Inc. Director Common Stock 19.1K $152K $7.97 30 May 2025 Direct
DBV Technologies S.A. CHIEF EXECUTIVE OFFICER, Director Employee Stock Option (right to buy) 964K 21 Nov 2025 Direct
REGENXBIO Inc. Director Stock Options (Right to Buy) 39.8K 30 May 2025 Direct
REGENXBIO Inc. Director Stock Options (Right to Buy) 24.5K 31 May 2024 Direct

Insider Reports Filed by Daniel Tasse

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DBVT DBV Technologies S.A. 21 Nov 2025 1 $0 4 CHIEF EXECUTIVE OFFICER, Director 24 Nov 2025, 19:05
RGNX REGENXBIO Inc. 30 May 2025 2 $0 4 Director 03 Jun 2025, 16:33
DBVT DBV Technologies S.A. 04 Dec 2024 1 $0 4 CHIEF EXECUTIVE OFFICER, Director 05 Dec 2024, 16:15
RGNX REGENXBIO Inc. 31 May 2024 2 $0 4 Director 04 Jun 2024, 16:40
DBVT DBV Technologies S.A. 08 Mar 2024 1 $14.2K 4 CHIEF EXECUTIVE OFFICER, Director 11 Mar 2024, 16:15
DBVT DBV Technologies S.A. 20 Nov 2023 1 $0 4 Chief Executive Officer, Director 22 Nov 2023, 07:04
RGNX REGENXBIO Inc. 02 Jun 2023 2 $0 4 Director 06 Jun 2023, 17:13
DBVT DBV Technologies S.A. 21 Nov 2022 1 $0 4 Chief Executive Officer, Director 14 Aug 2023, 17:32
RGNX REGENXBIO Inc. 03 Jun 2022 2 $0 4 Director 07 Jun 2022, 16:23
DBVT DBV Technologies S.A. 22 Nov 2021 1 $0 4 Chief Executive Officer, Director 24 Nov 2021, 15:15
RGNX REGENXBIO Inc. 04 Jun 2021 1 $0 4 Director 08 Jun 2021, 16:22